ARRA legislation

Attachment C: Section of the American Recovery and Reinvestment Act of 2009 (ARRA) relevant to 0920-0852, HAI and Antimicrobial Use Prevalence Survey

The section of the Act that is relevant appears on page H.R. 1-66 (copied below):

“PREVENTION AND WELLNESS FUND

(INCLUDING TRANSFER OF FUNDS)

For necessary expenses for a ‘‘Prevention and Wellness Fund’’

to be administered through the Department of Health and Human

Services, Office of the Secretary, $1,000,000,000: Provided, That

of the amount provided in this paragraph, $300,000,000 shall be

transferred to the Centers for Disease Control and Prevention

(‘‘CDC’’) as an additional amount to carry out the immunization

program (‘‘section 317 immunization program’’) authorized by section

317(a), (j), and (k)(1) of the Public Health Service Act (‘‘PHS

Act’’): Provided further, That of the amount provided in this paragraph,

$650,000,000 shall be to carry out evidence-based clinical

and community-based prevention and wellness strategies authorized

by the PHS Act, as determined by the Secretary, that deliver

specific, measurable health outcomes that address chronic disease

rates: Provided further, That funds appropriated in the preceding

proviso may be transferred to other appropriation accounts of the

Department of Health and Human Services, as determined by the

Secretary to be appropriate: Provided further, That of the amount

appropriated in this paragraph, $50,000,000 shall be provided to

States for an additional amount to carry out activities to implement

healthcare associated infections reduction strategies: Provided further,

That not more than 0.5 percent of funds made available

in this paragraph may be used for management and oversight

expenses in the office or division of the Department of Health

and Human Services administering the funds: Provided further,

That the Secretary shall, directly or through contracts with public

or private entities, provide for annual evaluations of programs

carried out with funds provided under this heading in order to

determine the quality and effectiveness of the programs: Provided

further, That the Secretary shall, not later than 1 year after the

date of enactment of this Act, submit to the Committees on Appropriations

of the House of Representatives and the Senate, the

Committee on Energy and Commerce of the House of Representatives,

and the Committee on Health, Education, Labor, and Pensions

of the Senate, a report summarizing the annual evaluations of

programs from the preceding proviso: Provided further, That the

Secretary shall provide to the Committees on Appropriations of

the House of Representatives and the Senate an operating plan

for the Prevention and Wellness Fund prior to making any Federal

obligations of funds provided in this paragraph (excluding funds

to carry out the section 317 immunization program), but not later

than 90 days after the date of enactment of this Act, that indicates

the prevention priorities to be addressed; provides measurable goals

for each prevention priority; details the allocation of resources

within the Department of Health and Human Services; and identifies

which programs or activities are supported, including descriptions

of any new programs or activities: Provided further, That

the Secretary shall provide to the Committees on Appropriations

of the House of Representatives and the Senate a report on the

actual obligations, expenditures, and unobligated balances for each

activity funded under this heading not later than November 1,

2009, and every 6 months thereafter as long as funding provided

under this heading is available for obligation or expenditure.”

As stated in the 2009 Funding Opportunity Announcement (CI09-90701ARRA09) issued by the Centers for Disease Control and Prevention for “American Recovery and Reinvestment Act (ARRA) Emerging Infections Programs (EIPs) Healthcare-Associated Infections Program - Innovations in the Surveillance of Mulitdrug-Resistant Organisms and Healthcare-Associated Infections,”

“The Prevention and Wellness Fund section of ARRA provides funding to the Office of

the Secretary (OS) of the Department of Health and Human Services (HHS) to be provided to States as an additional amount to carry out activities to reduce healthcare-associated infections. This Funding Opportunity Announcement (FOA) describes opportunities for ARRA HAI funding which will be awarded on behalf of the OS through CDC’s Emerging Infections Program (EIP) cooperative agreement” (page 2).

The HAI and Antimicrobial Use Prevalence Survey is described in Activity 2D of this Funding Opportunity Announcement: “Implement a hospital-wide HAI prevalence survey in accordance with a multi-site protocol developed by the EIP Network” (page 7).